+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Marathon Patent Group Announces Closing Of 250 0 Million Registered Direct Offering Of Common Stock is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Marathon Patent Group Announces Closing Of 250 0 Million Registered Direct Offering Of Common Stock | RobinsPost News & Noticias

Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


2024 of its previously announced registered direct offering priced at-the-market under the Nasdaq rules for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu ... Read More

BioXcel Therapeutics Announces $25 Million Registered Direct Offering


today announced that it has entered into a securities purchase agreement with investors in a registered direct offering of 3,054,609 shares (the “Shares”) of common stock, par value $0.001 per ... Read More

Danimer Scientific Announces Closing of $15 Million Registered Direct Offering


today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof ... Read More

NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering


today announced the closing of its previously announced registered direct offering of 7,000,000 of its common shares at a purchase price of $0.25 per share. NLS also issued in a private placement ... Read More

Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering


The combined offering price of each share of common stock and ... $24.0 million. The offering is expected to close on or about March 26, 2024, subject to customary closing conditions. Read More

GD Culture Group Limited Announces Registered Direct Offering


NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- GD Culture Group Limited ... the Company’s common stock, at a purchase price of $1.144 per share in a registered direct offering. Read More

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules


today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 147,500 shares of common stock at a purchase ... Read More

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price


in a registered direct offering. The price per ADS and accompanying warrant represents a premium of 10% over $0.5299, the closing price of the ADSs as reported by the Nasdaq Capital Market on ... Read More

NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement


All statements, statements relating to the concurrent registered direct offering ... timing of the closing of the offering. Forward-looking statements contained in this press release may be ... Read More

Danimer Scientific Announces Closing of $15 Million Registered Direct Offering


today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a ... Read More

Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


Genprex intends to use the net proceeds from this offering for working capital and general corporate purposes. This press release ... registered direct offering, the satisfaction of customary ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus